biuro@scopefluidics.com +48 22 376 21 14
biuro@scopefluidics.com +48 22 376 21 14
biuro@scopefluidics.com +48 22 376 21 14

RAPORT ESPI 3/2021 | 08-02-2021 | Zawiadomienie o zmianie stanu posiadania akcji Spółki

Previous PostNext Post

Related Posts

23.10.2025

Scope Fluidics establishes an international Clinical Advisory Board for the BACTEROMIC system

0
15.10.2025

Scope Fluidics reports positive results for the UNI FAST Panel and the PBC Panel

0
13.10.2025

Scope Fluidics appoints transaction advisor for the BACTEROMIC system

0